Alterola Biotech Stock Analysis
ABTI Stock | USD 0 0.00 0.00% |
Alterola Biotech is overvalued with Real Value of 0.00288 and Hype Value of 0.003375. The main objective of Alterola Biotech pink sheet analysis is to determine its intrinsic value, which is an estimate of what Alterola Biotech is worth, separate from its market price. There are two main types of Alterola Biotech's stock analysis: fundamental analysis and technical analysis.
The Alterola Biotech pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Alterola Biotech's ongoing operational relationships across important fundamental and technical indicators.
Alterola |
Alterola Pink Sheet Analysis Notes
The company recorded a loss per share of 0.01. Alterola Biotech had not issued any dividends in recent years. The entity had 10:1 split on the 26th of August 2010. Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products production of active pharmaceutical ingredients and food-grade ingredients and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech is traded on OTC Exchange in the United States.The quote for Alterola Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Alterola Biotech please contact David OBE at 44 1516 019 477 or go to https://alterola-abti.com.Alterola Biotech Investment Alerts
Alterola Biotech generated a negative expected return over the last 90 days | |
Alterola Biotech has high historical volatility and very poor performance | |
Alterola Biotech has some characteristics of a very speculative penny stock | |
Alterola Biotech has high likelihood to experience some financial distress in the next 2 years | |
Alterola Biotech currently holds 251.18 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Alterola Biotech has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Alterola Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Alterola Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alterola Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alterola to invest in growth at high rates of return. When we think about Alterola Biotech's use of debt, we should always consider it together with cash and equity. | |
Net Loss for the year was (6.47 M) with profit before overhead, payroll, taxes, and interest of 0. |
Alterola Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alterola Biotech's market, we take the total number of its shares issued and multiply it by Alterola Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 18th of January 2025, Alterola Biotech shows the Mean Deviation of 4.56, risk adjusted performance of (0.02), and Standard Deviation of 13.41. Alterola Biotech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Alterola Biotech Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Alterola Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Alterola Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Alterola Biotech Predictive Daily Indicators
Alterola Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Alterola Biotech pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Alterola Biotech Forecast Models
Alterola Biotech's time-series forecasting models are one of many Alterola Biotech's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Alterola Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Alterola Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Alterola Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Alterola shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Alterola Biotech. By using and applying Alterola Pink Sheet analysis, traders can create a robust methodology for identifying Alterola entry and exit points for their positions.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products production of active pharmaceutical ingredients and food-grade ingredients and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Alterola Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Complementary Tools for Alterola Pink Sheet analysis
When running Alterola Biotech's price analysis, check to measure Alterola Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterola Biotech is operating at the current time. Most of Alterola Biotech's value examination focuses on studying past and present price action to predict the probability of Alterola Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterola Biotech's price. Additionally, you may evaluate how the addition of Alterola Biotech to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Global Correlations Find global opportunities by holding instruments from different markets |